This study aims to understand why some people with follicular lymphoma (a type of slow-growing blood cancer) participate in clinical trials and others don't, and what helps them complete a trial. Historically, certain groups of people are less likely to join medical studies. This research will gather information from 500 participants to identify factors that make it difficult to enroll in and finish a follicular lymphoma clinical trial. The study will measure how many patients decide to join a trial (after 3 months) and how many stay in a trial until it's finished (after 12 months). The goal is to improve future clinical trial experiences for all follicular lymphoma patients, especially those from under-represented groups. You can join if you are 18 or older, have follicular lymphoma, and have internet access.

Study design

This is an observational study, meaning researchers will gather information without giving any specific treatments. It plans to include 500 participants.

What's involved

You would need access to a home internet connection to provide regular updates throughout the study.

Compensation

Not stated in the trial record.

Follow-up

The study measures how many patients remain in a medical study to trial completion at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.